Cargando…
PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma
BACKGROUND: Immune checkpoints like programmed cell death-1 (PD-1) and its ligand PD-L1 are involved in immune escape mechanisms of solid tumors including oral squamous cell carcinoma (OSCC). Inhibitors of the pathway are successfully used for treating especially advanced disease. However, the physi...
Autores principales: | Weber, Manuel, Wehrhan, Falk, Baran, Christoph, Agaimy, Abbas, Büttner-Herold, Maike, Preidl, Raimund, Neukam, Friedrich W., Ries, Jutta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762533/ https://www.ncbi.nlm.nih.gov/pubmed/29348848 http://dx.doi.org/10.18632/oncotarget.22576 |
Ejemplares similares
-
Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
por: Weber, Manuel, et al.
Publicado: (2019) -
Galectin 3 expression in primary oral squamous cell carcinomas
por: Weber, Manuel, et al.
Publicado: (2017) -
Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas
por: Wehrhan, Falk, et al.
Publicado: (2018) -
Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes – an immunohistochemical study
por: Wehrhan, Falk, et al.
Publicado: (2014) -
Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia
por: Ries, Jutta, et al.
Publicado: (2021)